Further Success for Link Technologies in Asia
News Feb 26, 2013
Following its announcement to expand into the Far East last month, certified specialist oligonucleotide reagent manufacturer Link Technologies Ltd, has agreed another distribution contract in Asia with Japanese company GeneDesign, Inc..
The deal comes just a few weeks after the signing of Zirench Technology for distribution in China.
Link Technologies is ISO 9001:2008 certified and manufacture a comprehensive range of reagents for DNA, RNA and PNA synthesis and modifications including a custom service for tailored compounds in specialist applications.
GeneDesign, located in Osaka, Japan, will represent Link Technologies throughout Japan and will be exhibiting at the forthcoming AsiaTIDES meeting on oligonucleotide and peptide research, technology and product development on February 26-28 in Tokyo, Japan.
Speaking about the agreement, Hideaki Sato, General Manager, Technical Support and Marketing at GeneDesign, Inc. said “Our collaboration with Link Technologies supports our goal of contributing to human welfare and health through nucleic acid technology development. We are delighted to be working with Link Technologies to increase the presence and usage of their high quality, reliable oligo precursor products in Japan. We invite people to visit us at the AsiaTIDES meeting to discover in detail the many benefits of these new offerings.”
Dr John Bremner, CEO at Link Technologies added “By working with GeneDesign we will be able to provide local access to our high quality products and offer our expert support services to customers throughout Japan. This level of accessibility is something we are very keen to continue to develop within Asia and worldwide, and forms part of our on-going strategic plans for development and growth. GeneDesign is a company that values the importance of this and we look forward to working with them.”
All in a Droplet: Atomic Resolution of ALS Protein ResolvedNews
Researchers have described atom-by-atom changes in a family of proteins linked to amyotrophic lateral sclerosis (ALS), a group of brain disorders known as frontotemporal dementia and degenerative diseases of muscle and bone.READ MORE